| Patents for A61P 23 - Anaesthetics (4,141) |
|---|
| 01/23/2003 | US20030015196 Aerosol forming device for use in inhalation therapy |
| 01/22/2003 | EP1276729A1 New neurokinin antagonists for use as medicaments |
| 01/22/2003 | EP1276480A1 Process of making racemic bupivacaine's enantiomers, levobupivacaine's pharmaceutical compositions, levobupivacaine's pharmaceutical compositions formulated on its free base form or its pharmaceutical acceptable salts and use of levobupivacaine's pharmaceutical compositions formulated on its free ba |
| 01/22/2003 | EP1276475A2 Topical anesthetic/opioid formulations and uses thereof |
| 01/22/2003 | EP1107738A4 Novel pharmaceutical salt form |
| 01/21/2003 | US6509028 Methods and compositions for treating pain of the mucous membrane |
| 01/16/2003 | WO2003004483A1 Substituted $g(g)-lactone compounds serving as nmda antagonists |
| 01/16/2003 | US20030013726 Sleep disorders; anxiolytic agents; muscle disease |
| 01/16/2003 | US20030013647 Selenocosmia huwena toxin and analgesic uses thereof |
| 01/15/2003 | EP1275374A1 Buccal, non-polar spray or capsule comprising analgesics or alkaloids |
| 01/15/2003 | EP1274709A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
| 01/15/2003 | EP1009524B1 Improvements in or relating to capsules |
| 01/15/2003 | EP0991405B1 Clear, injectable formulation of an anesthetic compound |
| 01/15/2003 | EP0769949B1 Hydromorphone therapy |
| 01/09/2003 | WO2002083674A3 Compositions containing imidazotriazinone for nasal application |
| 01/09/2003 | US20030008886 For therapy of pain |
| 01/08/2003 | EP0696197B1 Analgesic anaesthetic compositions |
| 01/08/2003 | CN1390121A Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 01/03/2003 | WO2003000699A1 Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 01/03/2003 | WO2002012501A3 Anti-dual integrin antibodies, compositions, methods and uses |
| 01/02/2003 | EP1268772A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 01/02/2003 | EP1268427A1 Aminopyridines and their use as anticonvulsants and sodium channel blockers |
| 12/31/2002 | US6500825 Substituted 2-aminoacetamides and the use thereof |
| 12/19/2002 | WO2002100386A1 Controlled heat induced rapid delivery of pharmaceuticals from skin depot |
| 12/19/2002 | US20020192288 Methods and compositions for treating pain of the mucous membrane |
| 12/19/2002 | CA2450366A1 Controlled heat induced rapid delivery of pharmaceuticals from skin depot |
| 12/18/2002 | EP1265901A2 Process for the preparation of midazolam |
| 12/18/2002 | EP1265866A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 12/18/2002 | EP1265618A1 Anaesthetic composition |
| 12/18/2002 | EP1265596A2 Medical emulsion for lubrication and delivery of drugs |
| 12/18/2002 | EP1079833A4 Cocaine receptor binding ligands |
| 12/18/2002 | CN1385153A Preparation process for surfacce anesthesia cream |
| 12/17/2002 | US6495681 Local anesthetic compounds and uses |
| 12/17/2002 | US6495584 Use of 3-(1H-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration |
| 12/12/2002 | WO2002098496A1 An aerosol forming device for use in inhalation therapy |
| 12/12/2002 | WO2002098390A2 Delivery of aerosols containing small particles through an inhalation route |
| 12/12/2002 | WO2002098389A1 Method of forming an aerosol for inhalation delivery |
| 12/12/2002 | US20020188000 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 12/11/2002 | EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 12/11/2002 | EP1263413A1 Method of preparing solid dispersions |
| 12/11/2002 | EP0750909B1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence |
| 12/11/2002 | EP0723447B1 Use of (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 12/10/2002 | US6491933 Personal care articles comprising hotmelt compositions |
| 12/05/2002 | WO2002000715A3 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 12/05/2002 | US20020183396 Local anesthetic methods and kits |
| 12/05/2002 | US20020183356 Local anesthetic methods and kits |
| 12/05/2002 | US20020183321 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 12/04/2002 | EP1054671B1 New use of ropivacaine for pain management |
| 11/28/2002 | WO2002094802A1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives |
| 11/28/2002 | WO2002094783A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 11/28/2002 | DE10125145A1 New C-furanyl- or C-thienyl-methylamine derivatives, useful e.g. for treating arrhythmia, emesis, inflammation, cardiovascular or neurodegenerative disease, asthma, glaucoma or especially pain |
| 11/28/2002 | CA2446313A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 11/27/2002 | EP1259226A2 Anaesthetic formulations |
| 11/27/2002 | EP1259223A1 Protein matrix materials, devices and methods of making and using thereof |
| 11/27/2002 | CN1094755C Controlled release agent containing reamine benzene ring alcohol or it salt |
| 11/21/2002 | WO2002072137A3 Anaesthetic formulation comprising articaine |
| 11/20/2002 | EP1257304A1 Foam-forming wound dressing |
| 11/20/2002 | EP1107732B1 Oral liquid mucoadhesive compositions |
| 11/14/2002 | WO2002090333A1 Novel pyridinone and related heterocyclic derivatives |
| 11/14/2002 | WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 11/14/2002 | WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives |
| 11/14/2002 | WO2002089783A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties |
| 11/14/2002 | WO2002089770A2 Topical lamellar double membrane structure composition containing n-acyl-ethanolamine and/or a quaternary ammonium salt and/or adenosylmethionine |
| 11/14/2002 | DE10213304A1 Topical pharmaceutical composition having carrier system forming lamellar double membrane structure with water, providing good skin barrier permeation and high bioavailability without side-effects |
| 11/14/2002 | CA2446735A1 Substituted cyclohexane-1,4-diamine derivatives with an anti-diarrhoea and peripheral analgesic action |
| 11/12/2002 | US6479484 Substituted 2-aminoacetamides and the discovery that these compounds act as blockers of sodium channels; pain relievers, treatment of arrythmia, local anesthetics |
| 11/07/2002 | US20020164789 Suppressing glial cell activation in central nervous system; obtain mammal with brain disorder, administer modulator of nervous system activity, evaluate for adjusstment in brain disorder |
| 11/05/2002 | US6475609 Glitter |
| 10/31/2002 | WO2002085863A1 Novel compounds of the family of 3-alkyl-(4,5 diphenyl-imidazol-1-yl) and their use as soothing agents |
| 10/31/2002 | WO2002085361A1 Benzimidazolone compounds |
| 10/31/2002 | WO2002085357A1 Nociceptin analogs |
| 10/31/2002 | WO2002085354A1 Spiroindene and spiroindane compounds |
| 10/31/2002 | US20020160043 Dissolvable drug-containing dosage form for use in transmucosal delivery of drug to patient, comprising binding agent formed into solid matrix dissolvable in mouth, pharmacologically effective dosage of drug, buffer |
| 10/30/2002 | EP1251857A1 Pharmaceutical parenteral composition containing a bisphosphonate |
| 10/30/2002 | EP1251853A1 Transdermal therapeutic system for the administration of zaleplon |
| 10/30/2002 | CN1377405A Personal care articles |
| 10/30/2002 | CN1376462A Prescription of tetracaine hydrochloride solution as mucose anesthetic |
| 10/29/2002 | US6471970 Use of pharmaceutical compositions capable of being gelled in periodontology |
| 10/24/2002 | WO2002083674A2 Compositions containing imidazotriazinone for nasal application |
| 10/24/2002 | WO2002083133A1 Novel oral general anesthetics and metabolitically resistant anticonvulsants |
| 10/24/2002 | WO2002083108A2 Compositions containing cgmp pde inhibitors and local anaesthetic agents for nasal application |
| 10/24/2002 | WO2002050057A8 Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders |
| 10/24/2002 | WO2002026958A3 Human neprilysin protease |
| 10/24/2002 | WO2001098265B1 Process for isolating enantiomers of racemic cetamine |
| 10/24/2002 | US20020156101 Use for pain management |
| 10/24/2002 | CA2443906A1 Novel oral general anesthetics and metabolitically resistant anticonvulsants |
| 10/24/2002 | CA2443639A1 Compositions containing imidazotriazinone for nasal application |
| 10/24/2002 | CA2443559A1 Compositions containing cgmp pde inhibitors and local anaesthetic agents for nasal application |
| 10/23/2002 | EP1250130A1 Propofol formulation with enhanced microbial inhibition |
| 10/23/2002 | CN1376065A Compositions having improved stability |
| 10/23/2002 | CN1376043A Drug delivery of phase changing formulation |
| 10/22/2002 | US6469069 Propofol composition containing sulfite |
| 10/17/2002 | WO2002080979A2 Conjugate of hydroxyalkyl starch and an active agent |
| 10/17/2002 | US20020150624 Mixture of drug, aminoacrylate polymer and acid |
| 10/17/2002 | DE10118306A1 Composition for intranasal administration of imidazo-triazinone derivative cGMP PDE inhibitor for treatment of erectile dysfunction, also containing local anesthetic to prevent nasal blockage and improve absorption |
| 10/17/2002 | DE10118305A1 Composition for intranasal administration of cGMP PDE inhibitor for treatment of erectile dysfunction, also containing local anesthetic to prevent nasal blockage and improve absorption |
| 10/17/2002 | CA2441442A1 Conjugate of hydroxyalkyl starch and an active agent |
| 10/15/2002 | USRE37886 4-(1-(3,5bis(trifluoromethyl) benzoyl)-2-(phenylmethyl)-4-piperidinyl)-n-(2,6dimethylphenyl)-1-piperazine acetamide, having tachykinin and substance p antagonistic activity; analgesic and antiinflammatory agents |
| 10/15/2002 | US6465478 Analgesics, antiinflammatories, diuretics, anesthetics, neuroprotective agents, antihypertensive or antianxiety agent, appetite control, hearing regulation |
| 10/15/2002 | US6464987 Pharmaceutical compositions capable of being gelled |